Largeaud, Laetitia
Bertoli, Sarah http://orcid.org/0000-0003-1084-2781
Bérard, Emilie
Tavitian, Suzanne
Picard, Muriel
Dufrechou, Stéphanie
Prade, Naïs
Vergez, François
Rieu, Jean Baptiste http://orcid.org/0000-0002-0950-979X
Luquet, Isabelle
Sarry, Audrey
Huguet, Françoise
Ruiz, Jean
De Mas, Véronique http://orcid.org/0000-0003-1878-9129
Delabesse, Eric
Récher, Christian http://orcid.org/0000-0002-3332-4525
Article History
Received: 26 October 2021
Revised: 24 November 2021
Accepted: 29 November 2021
First Online: 5 January 2022
Competing interests
: Christian Récher: Research grants (my institution): Abbvie, Amgen, Novartis, BMS-Celgene, Jazz Pharma, Agios, Daiichi-Sankyo, Astellas, Roche, MaatPharma, Iqvia. Advisory boards: Abbvie, Janssen, Jazz Pharma, Daiichi-Sankyo, Astellas, Novartis, Celgene, Takeda, Roche, Otsuka, Macrogenics, Pfizer; Sarah Bertoli: advisory role for Jazz Pharmaceuticals, Daiichi-Sankyo, Sanofi, Astellas and BMS; François Vergez: research grants from Pierre Fabre and Roche; is an advisor for Astellas and Amgen; Françoise Huguet: consultancy Novartis, Pfizer, Incyte; honoraria Amgen, Servier; Isabelle Luquet: advisory role for Jazz Pharmaceuticals.